New drink aims to help malnourished patients – but will they like it?
NCT ID NCT07452523
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new oral nutritional supplement called AYMES SWIFT in 40 adults who are malnourished or at risk of malnutrition. Participants will take the supplement for 7 days, and researchers will measure how well they tolerate it (digestive comfort) and how much they like it (taste, smell, texture). The goal is to see if this supplement is a good option for people who need extra nutrition due to illness.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AYMES SWIFT oral nutritional supplement (a food for special medical purposes)
- What this could lead to
- If successful, this could provide a well-tolerated and acceptable nutritional supplement for people with or at risk of disease-related malnutrition.
- What could go wrong
- This is a small, early-stage study focused on tolerance and acceptability, not on treating the underlying disease. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Oct 2022
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female •≥ 18 years of age * Identified as being malnourished/at risk of malnutrition-by-malnutrition screening tools \[i.e., MUST score ≥1, and/or using or requiring ONS at least once daily as part of nutritional management plan\] * Expected to receive at least one bottle of ONS per day * Written or electronic informed consent from patient, or verbally given consent countersigned by a witness for those physically unable to sign Exclusion Criteria: * Participants receiving parenteral nutrition or ≥70% total energy requirements from enteral tube feeding * Participants with major hepatic dysfunction (i.e., decompensated liver disease) * Participants with major renal dysfunction \[i.e., requiring filtration or stage 4/5 chronic kidney disease (CKD)\] * Participants with active/chronic gastrointestinal disease or impaired gastrointestinal function * Participants with significant dysphagia/high aspiration risk * Participation in other clinical intervention studies within 1 month of this study * Participants lacking mental capacity to consent * Allergy to any study product ingredients (appendix 2) * Investigator concern regarding ability or willingness of patient to comply with the study requirements.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Disease related malnutrition are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Preston Hill Surgery
Harrow, HA3 9SN, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.